Going the way of competitors Cellzome and Myriad Proteomics before it, Activx Biosciences, of La Jolla, Calif., has hired a new CEO to oversee its efforts to transform from a technology provider into a drug discovery company (see PM 9-23-02, 7-4-03).
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.
This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.